Guy Wendy's Form 4 filing
Processa Pharmaceuticals, Inc. (PCSA) · filed May 1, 2026
- Accession no.
- 0000897069-26-001002
- Filed
- May 1, 2026
- Trade date
- Apr 30, 2026
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction. Open-market purchases total $4.70K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Guy WendyCIK 0001799360 | Officer (Chief Administrative Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | Common Stock | PPurchaseAcquired | +1,748 | $2.69 | +$4,702.12 | 6,441 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.